Why do patients with McArdle's disease have decreased exercise capacity?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Disorders of myoglycogenolysis, such as myophosphorylase deficiency(McArdle's disease), and myoglycolysis, such as phosphofructokinase deficiency (Tarui disease), are characterized by electrically silent, exercise-provoked contractions called "contractures," premature exertional fatigue and excessive cardiovascular responses to exercise.1-3 McArdle's disease and Tarui disease as well as other disorders of myoglycolysis, such as phosphoglycerate kinase deficiency, phosphoglycerate mutase deficiency, and lactate dehydrogenase deficiency, are important to neurology because these disorders allow us to explore the interactions between muscle metabolism and muscle contraction.1 Beyond providing the power for movement, skeletal muscle is the largest protein store in the human body and is important in the regulation of glucose metabolism.4 The article by Haller et al.5 in this issue of Neurology focuses on physiologic alterations of skeletal muscle in McArdle's disease that contribute to exercise intolerance and exaggerated cardiovascular responses to exercise. Their work represents the collaboration of well-respected muscle physiologists from both sides of the Atlantic Ocean.
Contracture was initially thought to be similar to the rigor of rigor mortis. Ischemic exercise would deplete adenosine triphosphate (ATP) because the muscle fiber could not generate ATP through the glycolytic pathway under anaerobic conditions. Without …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
ARTICLES
Paradoxically enhanced glucose production during exercise in humans with blocked glycolysis caused by muscle phosphofructokinase deficiencyJohn Vissing, Henrik Galbo, Ronald G. Haller et al.Neurology, September 01, 1996 -
Article
Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiencyJohn Vissing, H. Orhan Akman, Jan Aasly et al.Neurology, August 15, 2018 -
Articles
No spontaneous second wind in muscle phosphofructokinase deficiencyRonald G. Haller, John Vissing et al.Neurology, January 12, 2004 -
Articles
Fat metabolism during exercise in patients with McArdle diseaseM. C. Ørngreen, T. D. Jeppesen, S. Tvede Andersen et al.Neurology, February 23, 2009